COVID-19期间长期护理机构临终症状管理药物处方的变化
该回顾性队列研究分析了加拿大安大略省626家长期护理机构中2017年1月1日至2021年3月31日死亡的75,438名居民,其中19,522名(25.9%)在COVID-19期间死亡。研究测量了居民临终前14天内皮下症状管理药物处方率,发现不同机构处方率差异大,低处方率机构在COVID-19期间处方率有所增加,且这些机构的COVID-19疫情更严重。
要点
- 长期护理机构临终症状管理药物处方率在COVID-19前后均存在较大差异。
- 低处方率机构在COVID-19期间平均处方率增加9.6%。
- 低处方率机构的COVID-19爆发比例、强度和持续时间更高,院外死亡比例更高。
核心结论
- 安大略省长期护理机构临终症状管理药物处方率在COVID-19前后差异较大,低处方率机构在COVID-19期间处方率有所增加,且这些机构的COVID-19疫情更严重。
研究设计与样本
- 回顾性队列研究,使用加拿大安大略省常规收集的健康行政数据,纳入2017年1月1日至2021年3月31日在长期护理机构死亡的所有居民,分为COVID-19前(2017年1月1日至2020年3月17日)和COVID-19期间(2020年3月18日至2021年3月31日)两个时期。
主要发现
- 共纳入75,438名长期护理机构死亡居民,其中19,522名(25.9%)在COVID-19期间死亡。
- COVID-19期间,最低处方五分位机构的平均处方率范围为46.9%至79.4%,最低处方五分位机构较COVID-19前平均处方率增加9.6%。
- 与最高处方五分位机构相比,最低处方五分位机构的COVID-19爆发比例更高(73.4% vs 50.0%),平均爆发强度更大(0.27 vs 0.09例/床),平均爆发总天数更长(72.7 vs 24.2天),转院并在院外死亡的比例更高(22.1% vs 8.6%)。
临床怎么用
- 长期护理机构应关注临终症状管理药物处方的规范性,尤其是低处方率机构。
- 在COVID-19等公共卫生危机期间,需加强低处方率机构的症状管理支持。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine changes in the prescribing of end-of-life symptom management medications in long-term care (LTC) homes during the COVID-19 pandemic. DESIGN: Retrospective cohort study using routinely collected health administrative data in Ontario, Canada. SETTING AND PARTICIPANTS: We included all individuals who died in LTC homes between January 1, 2017, and March 31, 2021. We separated the study into 2 periods: before COVID-19 (January 1, 2017, to March 17, 2020) and during COVID-19 (March 18, 2020, to March 31, 2021). METHODS: For each LTC home, we measured the percentage of residents who died before and during COVID-19 who had a subcutaneous symptom management medication prescription in their last 14 days of life. We grouped LTC homes into quintiles based on their mean prescribing rates before COVID-19, and examined changes in prescribing during COVID-19 and COVID-19 outcomes across quintiles. RESULTS: We captured 75,438 LTC residents who died in Ontario's 626 LTC homes during the entire study period, with 19,522 (25.9%) dying during COVID-19. The mean prescribing rate during COVID-19 ranged from 46.9% to 79.4% between the lowest and highest prescribing quintiles. During COVID-19, the mean prescribing rate in the lowest prescribing quintile increased by 9.6% compared to before COVID-19. Compared to LTC homes in the highest prescribing quintile, homes in the lowest prescribing quintile experienced the highest proportion of COVID-19 outbreaks (73.4% vs 50.0%), the largest mean outbreak intensity (0.27 vs 0.09 cases/bed), the highest mean total days with a COVID-19 outbreak (72.7 vs 24.2 days), and the greatest proportion of decedents who were transferred and died outside of LTC (22.1% vs 8.6%). CONCLUSIONS AND IMPLICATIONS: LTC homes in Ontario had wide variations in the prescribing rates of end-of-life symptom management medications before and during COVID-19. Homes in the lower prescribing quintiles had more COVID-19 cases per bed and days spent in an outbreak.
引用
- Fremont D, Roberts RL, Webber C, et al. Changes in End-of-Life Symptom Management Prescribing among Long-Term Care Residents during COVID-19. J Am Med Dir Assoc. 2024. PMID: 38438112. doi:10.1016/j.jamda.2024.01.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。